The endometrium in breast cancer patients on tamoxifen

Archives of Gynecology and Obstetrics

Volumn 263, Issue 4, 2000, Pages 170-177

  Dallenbach Hellweg, G ^a   Schmidt, D ^a   Hellberg, P ^b   Bourne, T ^c   Kreuzwieser, E ^a   Doren M ^c   Rydh, W ^b   Rudenstam, G ^b   Granberg, S ^b  

^a Institute für Pathologie   (Germany)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c NONE

Author keywords

Breast cancer; Endometrial carcinoma; Endometrium; Sonography; Tamoxifen

Indexed keywords

ANTIESTROGEN; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CARCINOSARCOMA; CLEAR CELL CARCINOMA; ENDOMETRIUM ATROPHY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METAPLASIA; PAPILLARY CARCINOMA;

EID: 0034020194     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004040050276     Document Type: Article

References (58)

1. Achiron R, Lipitz S, Silvan E, et al (1995) Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study. Ultrasound Obstet Gynecol 6:116-120
2. Achiron R, Lipitz S, Silvan E, et al (1995) Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium. J Ultrasound Med 14:685-588
3. Achiron R, Grisaru D, Golan-Porat N, et al (1996) Tamoxifen and the uterus: an old drug tested by new modalities. Ultrasound Obstet Gynecol 7:374-378
4. Altaras MM, Aviram R, Cohen I, et al (1993) Role of prolonged stimulation of tamoxifen therapy in the etiology of endometrial sarcomas. Gynecol Oncol 49:255-258
5. Ambros RA, Sherman ME, Zahn CM, et al (1995) Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol 26:1260-1267
6. Andersson M, Storm HH, Mouridsen HT (1991) Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst 83: 1013-1017
7. Assikis VCJ, Neven P, Jordan VC. et al (1996) A realistic clinical perspective of tamoxifen and endometrial carcinogenesis. Eur J Cancer 32 A:1464-1476
8. Bese T, Kosebay D, Demirkiran F, et al (1996) Ultrasonographic appearance of endometrium in postmenopausal breast cancer patients receiving tamoxifen. Eur J Obstet Gynecol Reprod Biol 67:157-162
9. Boccardo F, Bruzzi P, Rubagotti A, et al (1981) Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients. Oncology 38:218-285
10. Bocklage T, Lee KR, Belingson JL (1992) Uterine Muellerian adenosarcoma following adenomyoma in a woman on tamoxifen therapy. Gynecol Oncol 44:104-109
11. Bokhman JB, Maximov SJ (1993) Relative risk of development and active detection of primary multiple endometrial, breast and ovarian cancer. Eur J Gynaecol Oncol 14:114-118
12. Bourne T, Hamberger L, Hahlin M, et al (1997) Ultrasound in gynecology: endometrium, Int J Gynaecol Obstet 56:115-127
13. Candy J, Abell MR (1968) Progesteron-induced adenomatous hyperplasia of the uterine cervix. JAMA 203:323-326
14. Cecchini S, Ciatto S, Bonardi R et al (1996) Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen. Gynecol Oncol 60:409-411
15. Clarke MR (1993) Uterine malignant mixed Muellerian tumor in a patient on long-term tamoxifen therapy for breast cancer: case report. Gynecol Ocol 51:411-415
16. Cohen I, Rosen DJ, Shapira J, et al (1993) Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer. Br J Obstet Gynaecol 100:567-570
17. Cohen I, Rosen DJ, Shapira J, et al (1994) Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients. Gynecol Oncol 52:185-190
18. Cohen I, Altaras MM, Shapira J, et al (1994) Postmenopausal tamoxifen treatment and endometrial pathology. Obstet Gynecol Surv 49:823-829
19. Cohen I, Altaras MM, Shapira J, et al (1996) Time-dependent effect of tamoxifen therapy on endometrial pathology in asymptomatic postmenopausal breast cancer patients. Int J Gynecol Pathol 15:152-157
20. Corley D, Rowe J, Curtis MT, et al (1992) Postmenopausal bleeding form unusual endometrial polyps in women on chronic tamoxifen therapy. Obstet Gynecol 79:111-116
21. Dallenbach-Hellweg G (1984) On the origin and histological structure of adenocarcinoma of the endocervix in women under 50 years of age. Pathol Res Pract 179:38-50
22. Dallenbach-Hellweg G, Hahn U (1995) Mucinous and clear cell carcinomas of the endometrium in patients receiving antiestrogens (tamoxifen) and gestagens. Int J Gynecol Pathol 14:7-15
23. Dallenbach-Hellweg G, Hahn U, Schmidt D (1996) Morphologische Endometriumveränderungen unter Tamoxifen. Zentralbl Gynakol 118:365-369
24. Decensi A, Fontana V, Bruno S, et al (1996) Effect of tamoxifen on endometrial proliferation. J Clin Oncol 14:434-440
25. Deligdisch L. Holinka CF (1987) Endometrial carcinoma: two diseases? Cancer Detect Prev 10:237-246
26. De Muylder X, Neven P, Sesomer M, et al (1991) Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynecol Obstet 36:127-130
27. Fex G, Adielsson G, Mattson W (1981) Oestrogen-like effects of tamoxifen on the concentration of proteins in plasma. Acta Endocrinol 97:109-113
28. Fornander TT, Cedermark B, Mattson A, et al (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 21:117-120
29. Gallo MA, Kaufmann D (1997) Antagonistic and agonistic effects of tamoxifen: significance in human cancer. Semin Oncol [Suppl 1]24:71-80
30. Goldstein SR (1994) Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen. Am J Obstet Gynecol 170:447-451
31. Hann LE, Giess CS, Bach AM, et al (1997) Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings. AJR Am J Roentgenol 168:657-661
32. Hilliard GD, Norris HJ (1979) Pathologic effects of oral contraceptives. Recent Results Cancer Res 66:49-71
33. Ismail SM (1994) Pathology of endometrium treated with tamoxifen. J Clin Pathol 47:827-833
34. Jaiyesimi IA, Buzdar AU, Decker DA, et al (1995) Use of tamoxifen for breast cancer: twenty-eight years later. J Clin Oncol 13:513-529
35. Kedar RP, Bourne TH, Powles TJ, et al (1994) Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343: 1318-1321
36. Lahti E, Blanco G, Kauppila A, et al (1993) Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 81:660-664
37. Lamminen S, Rantala I, Helin H, et al (1992) Proliferative activity of human uterine leiomyoma cells as measured by automatic image analysis. Gynecol Obstet Invest 34:111-114
38. Lax SF, Pizer ES, Ronnett BM, et al (1998) Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Hum Pathol 29:551-558
39. Lerner JP, Timor-Tritsch IE, Monteagudo A (1996) Use of transvaginal sonography in the evaluation of endometrial hyperplasia and carcinoma. Obstet Gynecol Surv 51:718-725
40. Magriples U, Naftolin F, Schwartz PE, Carcangiu ML (1993) High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 11:485-490
41. Malfetano JH (1990) Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients. Gynecol Oncol 39:82-84
42. Maqueo M, Azuela JC, Calderon JJ, et al (1966) Morphology of the cervix in women treated with synthetic progestins. Am J Obstet Gynecol 96:994-998
43. Mourits MJE, Hollema H, Willemse PHB, et al (1998) Adenosarcoma of the uterus following tamoxifen treatment for breast cancer, Int J Gynecol Cancer 8:168-171
44. Nayfield SG, Karp JE, Ford LG, et al (1991) Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 83:1450-1459
45. Nuovo MA, Nuovo GJ, McCaffrey RM, et al (1989) Endometrial polyps in postmenopausal patients receiving tamoxifen. Int J Gynecol Pathol 8:125-131
46. Osmers R, Kuhn W (1998) Endometriumbeurteilung, myometriale Infiltrationstiefe und perioperatives Staging mit Hilfe des transvaginalen Ultraschalls bei Patientinnen mit Endometriumkarzinom. Jahrbuch d Gynäk u Geburtsh 1997/98: 153-159
47. Periwal SB, Farooq A, Bhargava VL, et al (1996) Effect of hormones and antihormones on phospholipase A2 activity in human endometrial stroma cells. Prostaglandins 51:191-201
48. Rageth JC, Bronz L, Granberg S (1995) Tamoxifen and Endometrium: Überwachung und Abklärung endometrialer Veränderungen. Arch Gynecol Obstet [Suppl] 256:122-127
49. Rutqvist LE, Johansson H, Signomklao T, et al (1995) Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst 87:645-651
50. Schlesinger C, Kamoi S, Ascher S, et al (1998) Endometrial polyps: a comparison study of patients receiving tamoxifen with two control gropus. Int J Gynecol Pathol 17:129-137
51. Schwartz LB, Krey L, Demopoulos R, et al (1997) Alterations in steroid hormone receptors in the tamoxifen-treated endometrium. Am J Obstet Gynecol 176:129-137
52. Segna RA, Dottino PR, Deligdisch L, Cohen CJ (1992) Tamoxifen and endometrial cancer. Mt Sinai J Med 59:416-418
53. Seoud MA, Johnson J, Weed JC Jr (1993) Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet Gynecol 82:165-169
54. Tepper R, Beyth Y, Altaras MM, et al (1997) Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients. Gynecol Oncol 64:386-391
55. Uziely B, Dorembus D, Brufman G, et al (1992) The effect of tamoxifen on the endometrium. Proc Annu Meet Am Assoc Cancer Res 33:A 1678
56. Van Leeuwen FE, Benraadt J, Coebergh JW, et al (1994) Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 343:448-452
57. Wells M, Tiltman T (1989) Intestinal metaplasia of the endometrium. Histopathology 15:431-433
58. Yokosuka K, Teshima H, Katase K, et al (1995) Effects of long-term administration of tamoxifen on vaginal epithelium and complications of endometrial lesions in breast cancer patients Nippon Sanka Fujinka Gakkai Zasshi 47:125-132